Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improvement on Diagnosis of Fetal Congenital Heart Disease Based on Multi-center Collaboration in China

NCT03119155 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT03119155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03119155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improvement on Diagnosis of Fetal Congenital Heart Disease Based on Multi-center Collaboration in China
Lead sponsor
Beijing Anzhen Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2018
Completion date
December 31, 2021
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, diagnosis, echocardiography